Your browser doesn't support javascript.
loading
Second- or third-generation tyrosine kinase inhibitors in first-line treatment of chronic myeloid leukemia in general population: Is there a real benefit?
Canet, Jim; Cony-Makhoul, Pascale; Orazio, Sébastien; Cornet, Edouard; Troussard, Xavier; Maynadié, Marc; Étienne, Gabriel; Monnereau, Alain.
  • Canet J; Bordeaux Population Health Research Center, Inserm UMR1219-EPICENE, University of Bordeaux, Bordeaux, France.
  • Cony-Makhoul P; Registre des Hémopathies Malignes de la Gironde, Institut Bergonié, Centre de lutte Contre le Cancer, Bordeaux, France.
  • Orazio S; IQVIA, Bordeaux, France.
  • Cornet E; FiLMC Group, Centre Léon Bérard, 28 Prom. Léa et Napoléon Bullukian, Lyon Cedex 8, France.
  • Troussard X; Bordeaux Population Health Research Center, Inserm UMR1219-EPICENE, University of Bordeaux, Bordeaux, France.
  • Maynadié M; Registre des Hémopathies Malignes de la Gironde, Institut Bergonié, Centre de lutte Contre le Cancer, Bordeaux, France.
  • Étienne G; Registre régional des Hémopathies Malignes de Basse-Normandie (RRHMBN), CHU Caen, Caen, France.
  • Monnereau A; Registre régional des Hémopathies Malignes de Basse-Normandie (RRHMBN), CHU Caen, Caen, France.
Cancer Med ; 10(20): 6959-6970, 2021 10.
Article en En | MEDLINE | ID: mdl-34551198

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Inhibidores de Proteínas Quinasas Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País como asunto: Europa Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Inhibidores de Proteínas Quinasas Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País como asunto: Europa Idioma: En Año: 2021 Tipo del documento: Article